Tag Archives: ICPT

Best High Tech Stocks To Invest In Right Now

&l;p&g;&l;img class=&q;dam-image ap size-large wp-image-f24eabe52b5040d8ba9fe4bd293e3d44&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/f24eabe52b5040d8ba9fe4bd293e3d44/960×0.jpg?fit=scale&q; data-height=&q;661&q; data-width=&q;960&q;&g; (AP Photo/Richard Drew, File)

&l;p class=&q;tweet_line&q;&g;The notion that August 22 marks the longest bull market history is meaningless. Since the S&a;amp;P 500 bottomed on March 9, 2009 there has been four bull markets followed by four corrections.

For this analysis I will focus on the S&a;amp;P 500, which set a &a;lsquo;panic low&a;rsquo; of 666.79 on March 9, 2009. Those of you who have been reading my analysis over the last 30-plus years know that I was pounding the table looking for a 20% to 40% rally from that low. This first bull market peaked at 1,217.28 during the week of April 23, 2010 for a bull market of 82.6%.

By definition a bull market ends with a correction of 10% or more. During the week of July 2, 2010, the S&a;amp;P 500 declined by 16.9% to 1,010.91.

Best High Tech Stocks To Invest In Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Max Byerly]

    JMP Securities upgraded shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from a market perform rating to an outperform rating in a research report report published on Wednesday morning, Marketbeat.com reports. JMP Securities currently has $175.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $75.00.

  • [By George Budwell]

    If that line holds true, this emerging space should be able to support multiple new drugs, meaning that the current leaders in the field — Intercept Pharmceuticals (NASDAQ:ICPT) and Genfit — probably won’t be able to monopolize the market before other competitors like Viking get their drugs past the FDA. In fact, this market is so large it could feasibly support several blockbuster level products. 

  • [By Chris Lange]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid (OCA) in patients with liver fibrosis due to nonalcoholic steatohepatitis (NASH).

  • [By George Budwell]

    Shares of Intercept Pharmaceuticals (NASDAQ:ICPT) rose by as much as 17% on above-average volume Monday. The spark?

    The drugmaker’s shares were responding positively to back-to-back upgrades from analysts at Goldman Sachs and Wedbush on Monday. For instance, Goldman’s Salveen Richter upgraded Intercept’s shares from a sell to a buy rating, and hiked the firm’s 12-month price target from $46 to $157 a share. Wedbush, on the other hand, doled out a $217 price target on the stock Monday morning. Wedbush’s noteworthy price target implies a monstrous 126% upside potential from where Intercept’s shares closed last week.  

  • [By Todd Campbell]

    However, neither of these companies may be the first to win an FDA OK in the indication. Gilead Sciences (NASDAQ:GILD) and Intercept (NASDAQ:ICPT) are already conducting phase 3 trials of their respective NASH drugs, and each of them expects to report data that could lead to an FDA filing for approval in 2019. Gilead Sciences plans to report data for selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor that seeks to reduce ASK1 activity to curb liver inflammation and scarring, and Intercept plans to report data for Ocaliva, a semisynthetic bile acid analogue FXR agonist that’s already FDA-approved for primary biliary cholangitis (PBC).

Best High Tech Stocks To Invest In Right Now: ServiceNow, Inc.(NOW)

Advisors’ Opinion:

  • [By ]

    The seven companies cited by Cramer are Salesforce.com Inc.  (CRM) , Workday Inc. (WDAY) , ServiceNow Inc. (NOW) , Splunk Inc. (SPLK) , New Relic Inc. (NEWR) , VMWare Inc. (VMW) , and Adobe Systems Incorporated (ADBE) .

  • [By Stephan Byrd]

    Investors sold shares of ServiceNow Inc (NYSE:NOW) on strength during trading on Thursday. $155.25 million flowed into the stock on the tick-up and $188.19 million flowed out of the stock on the tick-down, for a money net flow of $32.94 million out of the stock. Of all stocks tracked, ServiceNow had the 0th highest net out-flow for the day. ServiceNow traded up $2.83 for the day and closed at $174.97

  • [By Shane Hupp]

    Shares of ServiceNow Inc (NYSE:NOW) reached a new 52-week high on Tuesday . The stock traded as high as $202.72 and last traded at $199.87, with a volume of 63715 shares trading hands. The stock had previously closed at $198.23.

  • [By Joseph Griffin]

    ServiceNow (NYSE:NOW) has been given a $210.00 price objective by investment analysts at Macquarie in a research report issued on Friday. The firm currently has a “buy” rating on the information technology services provider’s stock. Macquarie’s price objective suggests a potential upside of 13.85% from the stock’s current price.

  • [By Motley Fool Staff]

    In this segment of the Motley Fool Money podcast, host Chris Hill and senior Fool analysts Jason Moser, David Kretzmann, and Jeff Fischer respond to a listener from across the pond who is feeling enthusiastic about ServiceNow (NYSE:NOW) and wants their views on the growing company and its enterprise software peers. They weigh in on the investment thesis.

  • [By Jeremy Bowman]

    Shares of ServiceNow (NYSE:NOW) climbed last month after the cloud-based IT solutions provider delivered another blowout earnings report. According to data from S&P Global Market Intelligence, the stock finished January up 24%. 

Best High Tech Stocks To Invest In Right Now: Brady Corporation(BRC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Brady Corp (NYSE:BRC) VP Thomas J. Felmer sold 3,703 shares of the company’s stock in a transaction on Friday, September 28th. The stock was sold at an average price of $43.76, for a total transaction of $162,043.28. Following the transaction, the vice president now owns 58,330 shares of the company’s stock, valued at approximately $2,552,520.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Brady (BRC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Northcoast Research reissued their buy rating on shares of Brady (NYSE:BRC) in a report released on Wednesday. Northcoast Research also issued estimates for Brady’s Q2 2019 earnings at $0.53 EPS, Q3 2019 earnings at $0.61 EPS, FY2019 earnings at $2.34 EPS, Q1 2020 earnings at $0.64 EPS, Q2 2020 earnings at $0.60 EPS, Q3 2020 earnings at $0.66 EPS and Q4 2020 earnings at $0.68 EPS.

  • [By Max Byerly]

    Brady (NYSE: BRC) and PlayAGS (NYSE:AGS) are both industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, earnings, analyst recommendations, risk and valuation.

  • [By Garrett Baldwin]

    Don’t Miss Out: The Treasury is sitting on an $11.1 billion cash pile, and a loophole entitles Americans to a sizable portion. Some are collecting $1,795, $3,000, or $5,000 every month thanks to this powerful investment…

    Stocks to Watch Today: KR, JPM, AAPL, BABA
    Kroger Co. (NYSE: KR) leads a busy day of earnings reports. The grocery giant reported adjusted earnings per share of $0.41, a figure that beat Wall Street estimates by $0.03. The firm also topped revenue expectations and issued a full-year forecast in line with analysts’ expectations. Is JPMorgan Chase & Co. (NYSE: JPM) CEO Jamie Dimon going to run against President Donald Trump in 2020? Some are speculating after Dimon said Wednesday that he could beat Trump because he is “smarter” than the president. Dimon also took at a shot at the original source of Trump’s wealth. “And by the way this wealthy New Yorker actually earned his money,” Dimon said. “It wasn’t a gift from daddy.” Shares of Apple Inc. (NASDAQ: AAPL) are on the move after the firm unveiled its new iPhone model during its annual September event. The company’s latest model is called the iPhone XS and XS Max and features a staggering 6.5-inch screen. The price point for the phone is $1,099 per unit. The firm also unveiled a new Apple Watch, which features a larger display and a built-in electrocardiogram. Alibaba Group Holding Ltd. (NYSE: BABA) generated a lot of attention last week after Jack Ma announced that he would step down from his role of executive chair. That has fueled a dip in the stock and has left a lot of Alibaba shares at “on sale” prices. In fact, Wall Street believes that an 83% gain is on the horizon. But Money Morning Executive Editor Bill Patalon thinks that this stock is going way higher than a $293 analyst target. Look for earnings reports from Adobe Systems Inc. (NASDAQ: ADBE), Fred’s Inc. (NASDAQ: FRED), and Brady Corp. (NYSE: BRC).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Best Buy Co., Inc. (NYSE: BBY) is projected to report quarterly earnings at $0.74 per share on revenue of $8.73 billion.
    McKesson Corporation (NYSE: MCK) is expected to report quarterly earnings at $3.56 per share on revenue of $51.25 billion.
    Medtronic plc (NYSE: MDT) is estimated to report quarterly earnings at $1.39 per share on revenue of $8.00 billion.
    Hormel Foods Corporation (NYSE: HRL) is projected to report quarterly earnings at $0.45 per share on revenue of $2.39 billion.
    Brady Corporation (NYSE: BRC) is expected to report quarterly earnings at $0.49 per share on revenue of $291.47 million.
    Sanderson Farms, Inc. (NASDAQ: SAFM) is projected to report quarterly earnings at $2.2 per share on revenue of $841.75 million.
    The Toronto-Dominion Bank (NYSE: TD) is estimated to report quarterly earnings at $1.16 per share on revenue of $6.86 billion.
    Royal Bank of Canada (NYSE: RY) is expected to report quarterly earnings at $1.61 per share on revenue of $8.05 billion.
    58.com Inc. (NYSE: WUBA) is projected to report quarterly earnings at $0.21 per share on revenue of $372.49 million.
    Luxoft Holding, Inc. (NYSE: LXFT) is estimated to report quarterly earnings at $0.59 per share on revenue of $228.53 million.
    The Toro Company (NYSE: TTC) is expected to report quarterly earnings at $1.21 per share on revenue of $916.73 million.
    StealthGas Inc. (NASDAQ: GASS) is projected to report quarterly earnings at $0.06 per share on revenue of $37.75 million.
    Stage Stores, Inc. (NYSE: SSI) is estimated to report earnings for its first quarter.
    Thermon Group Holdings, Inc. (NYSE: THR) is projected to report quarterly earnings at $0.2 per share on revenue of $96.24 million.
    Tuniu Corporation (NASDAQ: TOUR) is estimated to report quarterly loss at $0.03 per share on revenue of $76.72 million.

     

Best High Tech Stocks To Invest In Right Now: First Trust Water ETF (FIW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Wells Fargo & Company MN decreased its stake in shares of First Trust Water ETF (NYSEARCA:FIW) by 11.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,540 shares of the company’s stock after selling 36,231 shares during the quarter. Wells Fargo & Company MN’s holdings in First Trust Water ETF were worth $13,256,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Raymond James & Associates increased its position in First Trust Water ETF (NYSEARCA:FIW) by 45.0% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 61,717 shares of the company’s stock after buying an additional 19,152 shares during the period. Raymond James & Associates’ holdings in First Trust Water ETF were worth $2,969,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    First Trust ISE Water Index Fund (NYSEARCA:FIW) declared a quarterly dividend on Thursday, June 21st, Wall Street Journal reports. Shareholders of record on Friday, June 22nd will be paid a dividend of 0.0861 per share on Friday, June 29th. This represents a $0.34 dividend on an annualized basis and a yield of 0.71%. The ex-dividend date of this dividend is Thursday, June 21st. This is a positive change from First Trust ISE Water Index Fund’s previous quarterly dividend of $0.06.

Best High Tech Stocks To Invest In Right Now: C.H. Robinson Worldwide, Inc.(CHRW)

Advisors’ Opinion:

  • [By Asit Sharma]

    Landstar is benefiting, of course, from tight capacity in the freight truck market. As I noted last month, John Wiehoff, CFO of fellow 3PL provider C.H. Robinson Worldwide (NASDAQ:CHRW), recently gave an informative rundown of the factors contributing to the utilization of supply in the trucking market. These include an expanding U.S. economy, a shrinking pool of skilled truck drivers, rising e-commerce related shipping demand, and the recently implemented “ELD” (electronic logging device) regulations mandated by Congress. ELD seeks to make trucking safer through the implementation of advanced monitoring of the hours truck drivers log.

  • [By Max Byerly]

    Envestnet Asset Management Inc. trimmed its position in shares of C.H. Robinson Worldwide Inc (NASDAQ:CHRW) by 95.0% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 8,737 shares of the transportation company’s stock after selling 165,535 shares during the quarter. Envestnet Asset Management Inc.’s holdings in C.H. Robinson Worldwide were worth $813,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on C.H. Robinson Worldwide (CHRW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019

Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €107.00 ($124.42) price target from equities researchers at HSBC in a note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.04% from the stock’s current price.

FME has been the subject of several other reports. JPMorgan Chase & Co. set a €96.10 ($111.74) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday, July 26th. Barclays set a €90.00 ($104.65) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Friday, May 4th. Berenberg Bank set a €100.80 ($117.21) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Tuesday, July 31st. Credit Suisse Group set a €91.00 ($105.81) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Finally, Commerzbank set a €82.00 ($95.35) price target on Fresenius Medical Care AG & Co. KGaA and gave the company a “neutral” rating in a research note on Tuesday, July 31st. Nine investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of €95.23 ($110.73).

Top 10 Medical Stocks To Invest In 2019: SteadyMed Ltd.(STDY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Steadymed Ltd (NASDAQ:STDY) CEO Jonathan Rigby sold 88,831 shares of the company’s stock in a transaction on Friday, August 17th. The stock was sold at an average price of $4.66, for a total transaction of $413,952.46. Following the completion of the sale, the chief executive officer now owns 41,605 shares of the company’s stock, valued at $193,879.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Top 10 Medical Stocks To Invest In 2019: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    It’s another disappointing day for one of America’s top biotech companies. Gilead Sciences Inc.’s (NASDAQ: GILD) selonsertib failed to improve fibrosis in the Phase 3 STELLAR-4 trial, and its shares traded lower as a result. While this is more bad news for Gilead, it may prove to be great news for Intercept Pharmaceuticals Inc. (NASDAQ: ICPT).

  • [By Max Byerly]

    JMP Securities upgraded shares of Intercept Pharmaceuticals (NASDAQ:ICPT) from a market perform rating to an outperform rating in a research report report published on Wednesday morning, Marketbeat.com reports. JMP Securities currently has $175.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $75.00.

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

Top 10 Medical Stocks To Invest In 2019: Phillips 66(PSX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Refining giant Phillips 66 (NYSE:PSX) and Canadian energy infrastructure behemoth Enbridge (NYSE:ENB) initially pitched Gray Oak to oil shippers in early December. At the time, they envisioned a 385,000 barrel-a-day pipeline that would move crude from several connection points in West Texas to refineries and export docks along the Texas coast starting in the second half of 2019.

  • [By Reuben Gregg Brewer]

    In January, oil and natural gas refinery Valero Energy Corporation’s (NYSE:VLO) shares jumped 17%, according to data provided by S&P Global Market Intelligence. That was the biggest gain of this trio, but Marathon Petroleum Corp. (NYSE:MPC) and its 12% gain wasn’t far behind. Even Phillips 66 (NYSE:PSX) got in the act with a nearly 11% gain. All of them beat the roughly 8% rise in the S&P 500 index.

  • [By Max Byerly]

    Phillips 66 (NYSE: PSX) and Vertex Energy (NASDAQ:VTNR) are both oils/energy companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

  • [By Shane Hupp]

    HPM Partners LLC grew its position in Phillips 66 (NYSE:PSX) by 10.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,411 shares of the oil and gas company’s stock after buying an additional 1,059 shares during the period. HPM Partners LLC’s holdings in Phillips 66 were worth $1,282,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Payden & Rygel lifted its stake in shares of Phillips 66 (NYSE:PSX) by 46.2% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 199,700 shares of the oil and gas company’s stock after buying an additional 63,100 shares during the quarter. Phillips 66 makes up approximately 1.6% of Payden & Rygel’s portfolio, making the stock its 25th biggest position. Payden & Rygel’s holdings in Phillips 66 were worth $19,155,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In 2019: Altisource Residential Corporation(RESI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Front Yard Residential Corp (NYSE:RESI) was the target of some unusual options trading activity on Thursday. Traders bought 3,877 put options on the company. This is an increase of approximately 899% compared to the average volume of 388 put options.

  • [By Logan Wallace]

    Vonovia SE Depository Receipt (NYSE: RESI) and Front Yard Residential (NYSE:RESI) are both finance companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Logan Wallace]

    Front Yard Residential (NYSE:RESI) issued its quarterly earnings data on Tuesday. The real estate investment trust reported ($0.51) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.02), Morningstar.com reports. Front Yard Residential had a negative return on equity of 25.77% and a negative net margin of 196.93%.

Top 10 Medical Stocks To Invest In 2019: VOC Energy Trust(VOC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Deutsche Bank AG reduced its position in VOC Energy Trust (NYSE:VOC) by 64.5% in the 4th quarter, Holdings Channel reports. The firm owned 19,000 shares of the oil and gas producer’s stock after selling 34,500 shares during the period. Deutsche Bank AG’s holdings in VOC Energy Trust were worth $112,000 as of its most recent filing with the SEC.

Top 10 Medical Stocks To Invest In 2019: Encana Corporation(ECA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Encana (NYSE:ECA) (TSE:ECA) had its target price raised by Morgan Stanley from $16.00 to $20.00 in a research report report published on Wednesday morning. Morgan Stanley currently has a buy rating on the oil and gas company’s stock.

  • [By Stephan Byrd]

    Cenovus Energy (NYSE:CVE) and Encana (NYSE:ECA) are both large-cap oils/energy companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

  • [By Max Byerly]

    Here are some of the news stories that may have effected Accern Sentiment’s rankings:

    Get Encana alerts:

    Encana Corp (ECA) Rising Higher 7.95% Over the Past Four Weeks (fisherbusinessnews.com) Encana Corporation (ECA) Most Active Stock Price trades 19.10% off from 200- SMA (nasdaqchronicle.com) Mid-Day Movers –: Encana Corporation (NYSE:ECA), CSX Corporation (NASDAQ:CSX), MGIC Investment Corporation … (journalfinance.net) Featured Stock: Encana Corporation (ECA) (stockquote.review) Active Stock Evaluation – Encana Corporation (NYSE: ECA) (financerater.com)

    ECA has been the subject of a number of research analyst reports. Morgan Stanley raised shares of Encana from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $15.00 to $18.00 in a report on Wednesday, January 24th. Evercore ISI raised shares of Encana from an “in-line” rating to an “outperform” rating and upped their price target for the company from $10.84 to $16.00 in a report on Wednesday, March 7th. Zacks Investment Research downgraded shares of Encana from a “hold” rating to a “sell” rating in a report on Wednesday, January 31st. Scotiabank raised shares of Encana from a “sector perform” rating to an “outperform” rating and upped their price target for the company from $13.00 to $14.00 in a report on Friday, February 16th. Finally, Goldman Sachs cut their price target on shares of Encana from $17.25 to $14.00 and set a “buy” rating for the company in a report on Friday, April 13th. Two analysts have rated the stock with a sell rating, two have given a hold rating, twenty-two have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $15.28.

  • [By Ethan Ryder]

    Electra (CURRENCY:ECA) traded down 22.1% against the dollar during the 1 day period ending at 11:00 AM Eastern on August 14th. One Electra coin can currently be purchased for approximately $0.0004 or 0.00000007 BTC on cryptocurrency exchanges including Cryptohub, CryptoBridge, Cryptopia and Novaexchange. In the last seven days, Electra has traded 36.7% lower against the dollar. Electra has a total market capitalization of $11.78 million and approximately $119,848.00 worth of Electra was traded on exchanges in the last day.

Top 10 Medical Stocks To Invest In 2019: ProShares UltraShort Nasdaq Biotechnology(BIS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Bismuth (BIS) uses the hashing algorithm. Its genesis date was May 1st, 2017. Bismuth’s total supply is 11,579,876 coins and its circulating supply is 11,011,069 coins. The Reddit community for Bismuth is /r/cryptobismuth and the currency’s Github account can be viewed here. The official message board for Bismuth is bismuth.cz/forum. Bismuth’s official Twitter account is @cryptobismuth and its Facebook page is accessible here. The official website for Bismuth is bismuth.cz.

  • [By Ethan Ryder]

    Bismuth (BIS) uses the hashing algorithm. Its launch date was May 1st, 2017. Bismuth’s total supply is 10,193,595 coins and its circulating supply is 9,644,979 coins. The Reddit community for Bismuth is /r/cryptobismuth and the currency’s Github account can be viewed here. The official website for Bismuth is bismuth.cz. Bismuth’s official Twitter account is @cryptobismuth and its Facebook page is accessible here. The official message board for Bismuth is bismuth.cz/forum.

  • [By Shane Hupp]

    News articles about ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) have trended somewhat positive recently, Accern Sentiment reports. Accern identifies positive and negative press coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. ProShares UltraShort Nasdaq Biotechnology earned a news impact score of 0.15 on Accern’s scale. Accern also gave news headlines about the company an impact score of 46.2593843139852 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Bismuth (CURRENCY:BIS) traded 8.1% lower against the US dollar during the 24-hour period ending at 21:00 PM ET on June 17th. Bismuth has a total market cap of $14.34 million and $48,199.00 worth of Bismuth was traded on exchanges in the last day. One Bismuth coin can now be purchased for $1.35 or 0.00020851 BTC on major exchanges including Cryptopia and Octaex. During the last week, Bismuth has traded down 8.5% against the US dollar.

Top 10 Medical Stocks To Invest In 2019: Pluristem Therapeutics Inc.(PSTI)

Advisors’ Opinion:

  • [By Max Byerly]

    Momenta Pharmaceuticals (NASDAQ: MNTA) and Pluristem Therapeutics (NASDAQ:PSTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, risk, valuation and analyst recommendations.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Pluristem Therapeutics (PSTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Pluristem Therapeutics Inc. (NASDAQ:PSTI) has been given a consensus recommendation of “Buy” by the six brokerages that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company. The average 1 year target price among brokers that have covered the stock in the last year is $4.00.

Top 10 Medical Stocks To Invest In 2019: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Shane Hupp]

    FinnCap cut shares of Avingtrans (LON:AVG) to a corporate rating in a research report report published on Monday.

    Shares of LON:AVG opened at GBX 223 ($2.97) on Monday. Avingtrans has a one year low of GBX 174.11 ($2.32) and a one year high of GBX 260 ($3.46).

Top 10 Medical Stocks To Invest In 2019: PetMed Express, Inc.(PETS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Petmed Express (NASDAQ:PETS) have been trending somewhat positive recently, according to Accern. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Petmed Express earned a news impact score of 0.05 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 47.0051994773148 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Steve Symington]

    Nevertheless, several individual stocks failed to keep up. Read on to see why CTI BioPharma (NASDAQ:CTIC), PetMed Express (NASDAQ:PETS), and Pfizer (NYSE:PFE) each slumped today.

  • [By Jason Hall, George Budwell, and Daniel Miller]

    For instance, TerraForm Power Inc. (NASDAQ:TERP) is easy to miss because it operates in what’s still something of a niche: owning renewable energy projects and selling the electricity to utilities and industrial users. Then you have Stanley Black & Decker, Inc. (NYSE:SWK), the company behind a handful of relatively well-known tool brands but not one that’s widely known among investors. It can get even more obscure, like Petmed Express Inc. (NASDAQ:PETS), the online pet pharmacy that’s certainly not a household name for most people and certainly not investors. 

  • [By Logan Wallace]

    Petmed Express Inc (NASDAQ:PETS) has received an average rating of “Hold” from the nine research firms that are presently covering the firm, MarketBeat reports. Three equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $39.00.

  • [By ]

    PetMed Express (PETS) : “No, no, no, no. When we want pet drugs, we want Idexx Laboratories (IDXX) .”

    Xerox (XRX) : “I’d sell Xerox. That’s a house of pain.”

  • [By Timothy Green, Tyler Crowe, and Sean Williams]

    Three of our Motley Fool contributors want you to know about A.O. Smith (NYSE:AOS), Kulicke & Soffa Industries (NASDAQ:KLIC), and PetMed Express (NASDAQ:PETS). Read on to find out why these unknown but amazing dividend stocks belong in your portfolio.

Top 10 High Tech Stocks To Own Right Now

Later this year, Alphabet’s (NASDAQ:GOOGL) (NASDAQ:GOOG) self-driving car company, Waymo, expects to launch a public robotaxi servicein several cities that will allow people to hail self-driving cars. Meanwhile, electric automakerTeslahas said that one of its vehicles will driveitself across the country within the next six months. And chipmaker NVIDIA (NASDAQ: NVDA) says 25 automakers are using latest version of its autonomous driving supercomputer to create fully autonomous vehicles, some of which will be available by 2021.

These announcements show just how quickly driverless car technologies are advancing. But there’s also evidence that a large portion of the general public isn’t quite ready to embrace autonomous vehicles.

According to a new J.D. Power/Miller Canfieldreport, 29% of respondents said they “probably would not” ride in a fully autonomous vehicle, and 17% said they “definitely would not.” Even when those skeptical 46% of respondents were specifically asked how they’d feel about using anautonomous vehicle if it met all government safety standards, 78% said they’d still be reluctant to set foot in one.

Top 10 High Tech Stocks To Own Right Now: National Steel Corporation(SID)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Companhia Siderurgica Nacional (NYSE:SID)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $1.95 and last traded at $1.99, with a volume of 131251 shares. The stock had previously closed at $2.02.

  • [By Dan Caplinger]

    Monday began the week on a solid note for the stock market, with the Dow Jones Industrial Average posting another triple-digit gain as the Nasdaq Compositeclosed at a record high. Despite ongoing nervousness regarding trade, most investors remain convinced that the strong U.S. economy will be able to lead the way forward, pointing to Friday’s employment report as the latest evidence of sustainable momentum. Good news regarding a host of companies both in the U.S. and abroad also helped buoy the market’s mood. Fossil Group (NASDAQ:FOSL), Companhia Siderurgica Nacional (NYSE:SID), and Immunomedics (NASDAQ:IMMU) were among the best performers on the day. Here’s why they did so well.

  • [By Ethan Ryder]

    Daiwa Securities Group Inc. reduced its stake in shares of Companhia Sider煤rgica Nacional (NYSE:SID) by 10.2% during the 1st quarter, Holdings Channel reports. The firm owned 374,200 shares of the basic materials company’s stock after selling 42,600 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Companhia Sider煤rgica Nacional were worth $984,000 at the end of the most recent reporting period.

  • [By Rich Smith]

    Brazilian steelmaker Companhia Siderurgica Nacional (NYSE:SID) stock lost 20% of its value in last month’s sell-off, hurt by a shareholder dispute with management and (probably) continued generally negative sentiment regarding South American stocks. This morning, however, shares of CSN are turning around, and trading up 13% as of 12:30 p.m. EDT.

  • [By Rich Smith]

    Confirming that this was not an “oil story” but a “Brazil story,” shares of Brazilian airline Azul SA (NYSE:AZUL) and Brazilian steel company Companhia Siderurgica Nacional (NYSE:SID) likewise declined steeply — closing down 7.2% and 4.8%, respectively. Overall, the Brazilian Ibovespa benchmark stock index closed down 3.7%, after falling as much as 6% in trading earlier in the day.

Top 10 High Tech Stocks To Own Right Now: Independent Bank Corporation(IBCP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Independent Bank Co.(MI) (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Independent Bank (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Independent Bank Co.(MI) (IBCP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub lowered shares of Independent Bank (NASDAQ:IBCP) from a buy rating to a hold rating in a research note issued to investors on Friday.

    IBCP has been the topic of several other reports. Zacks Investment Research lowered Independent Bank from a buy rating to a hold rating in a report on Wednesday, February 28th. ValuEngine raised Independent Bank from a hold rating to a buy rating in a report on Tuesday, April 24th. Boenning Scattergood reissued a hold rating on shares of Independent Bank in a report on Tuesday, April 24th. Finally, Hovde Group set a $26.00 price objective on Independent Bank and gave the company a hold rating in a report on Tuesday, April 24th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Independent Bank presently has a consensus rating of Hold and a consensus target price of $25.25.

Top 10 High Tech Stocks To Own Right Now: CHS Inc(CHSCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 10 High Tech Stocks To Own Right Now: Rent-A-Center Inc.(RCII)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Monday was a weak day for the stock market, with most major benchmarks losing ground. Further concerns about the potential for a deepening divide between the U.S. and China weighed on sentiment, and some also fear that steadily rising interest rates could eventually put pressure on stocks. Yet some companies still had good news that sent their individual shares higher. Rent-A-Center (NASDAQ:RCII), PTC Therapeutics (NASDAQ:PTCT), and Dropbox (NASDAQ:DBX) were among the best performers on the day. Here’s why they did so well.

  • [By ]

    Engaged Capital maintained large positions in Rent-A-Center (RCII) , TiVo (TIVO) , Hain Celestial (HAIN) , SunOpta and Jamba Inc. (JMBA) , all companies that have either previously been targeted by Welling or currently are in his cross-hairs.

  • [By Logan Wallace]

    AerCap (NYSE: AER) and Rent-A-Center (NASDAQ:RCII) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, analyst recommendations and valuation.

  • [By Chris Lange]

    Rent-A-Center Inc. (NASDAQ: RCII) shares made an incredible gain on Monday after the company announced that it would be taken private by Vintage Rodeo Parent, an affiliate of Vintage Capital Management.

Top 10 High Tech Stocks To Own Right Now: CSX Corporation(CSX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CSX (CSX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Hill]

    But there was more upbeat news elsewhere, with No. 3 airline United Continental(NYSE:UAL) beating on earnings and freight rail titan CSX(NASDAQ:CSX) delivering record first-quarter numbers. Also on the rapid growth train: Intuitive Surgical(NASDAQ:ISRG), whose da Vinci systems are selling at an impressive rate. And speaking of sales of tech products, the guys close out the episode by explaining why it’s a win-win that Amazon.com(NASDAQ:AMZN) and Best Buy(NYSE:BBY) are joining forces to sell smart TVs.

  • [By ]

    CSX Corp. (CSX) shares jumped in after-hours trading Tuesday, April 17, after reporting a top- and bottom-line beat for the first quarter, driven by lower costs and restructuring expenses.

  • [By Asit Sharma]

    CSX Corporation (NASDAQ:CSX)surprised investors with extremely healthy results on its release of first-quarter 2018 earnings Tuesday after the markets closed. While lower volumes compressed the company’s top line, leading to essentially flat revenue of $2.9 billion, net income soared 92%, to $695 million, due to cost-cutting and the fruit of productivity initiatives. Shares responded in kind, as CSX stock gained nearly 8% in Wednesday’s trading session.

  • [By Ethan Ryder]

    CSX Co. (NASDAQ:CSX) CEO James M. Foote bought 5,000 shares of the firm’s stock in a transaction on Wednesday, May 2nd. The stock was acquired at an average price of $59.91 per share, for a total transaction of $299,550.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Top 10 High Tech Stocks To Own Right Now: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Oppenheimer Asset Management Inc. decreased its position in Avery Dennison Corp (NYSE:AVY) by 9.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,671 shares of the industrial products company’s stock after selling 1,265 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Avery Dennison were worth $1,240,000 at the end of the most recent quarter.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Avery Dennison alerts:

    Avery Dennison (AVY) Shares Cross Below 200 DMA (nasdaq.com) Avery Dennison (AVY) Given Average Rating of “Buy” by Brokerages (americanbankingnews.com) Concern in Framingham about environmental contamination (metrowestdailynews.com) Avery Dennison (AVY) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com) Avery Dennison (AVY) Upgraded at Zacks Investment Research (americanbankingnews.com)

    Several equities research analysts recently commented on AVY shares. Citigroup dropped their price objective on Avery Dennison from $140.00 to $125.00 and set a “buy” rating on the stock in a research report on Thursday, April 5th. Zacks Investment Research raised Avery Dennison from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research report on Monday, February 5th. UBS started coverage on Avery Dennison in a research report on Thursday, January 18th. They set a “buy” rating and a $135.00 price objective on the stock. Bank of America increased their price objective on Avery Dennison from $128.00 to $133.00 and gave the company a “buy” rating in a research report on Thursday, February 1st. Finally, KeyCorp reaffirmed a “hold” rating on shares of Avery Dennison in a research report on Wednesday, April 25th. Five research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $123.00.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 High Tech Stocks To Own Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By George Budwell]

    If that line holds true, this emerging space should be able to support multiple new drugs, meaning that the current leaders in the field –Intercept Pharmceuticals (NASDAQ:ICPT) and Genfit — probably won’t be able to monopolize the market before other competitors like Viking get their drugs past the FDA. In fact, this market is so large it could feasibly support several blockbuster level products.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Intercept Pharmaceuticals (ICPT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams]

    As you can see, there’s a lot of excitement in the NASH space at the moment, and plenty of big drug stocks are itching to add a promising NASH drug to their product pipelines. But one name that continues to be left out in the cold is Intercept Pharmaceuticals (NASDAQ:ICPT).

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 High Tech Stocks To Own Right Now: DCT Industrial Trust Inc(DCT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of DCT Industrial Trust Inc (NYSE:DCT) by 7.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,570 shares of the real estate investment trust’s stock after acquiring an additional 1,044 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in DCT Industrial Trust were worth $821,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Stephan Byrd]

    Daiwa Securities Group Inc. lifted its holdings in DCT Industrial Trust Inc (NYSE:DCT) by 25.5% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 19,700 shares of the real estate investment trust’s stock after purchasing an additional 4,000 shares during the period. Daiwa Securities Group Inc.’s holdings in DCT Industrial Trust were worth $1,110,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on DCT Industrial Trust (DCT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Teza Capital Management LLC bought a new stake in DCT Industrial Trust Inc (NYSE:DCT) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 6,379 shares of the real estate investment trust’s stock, valued at approximately $359,000.

Top 10 High Tech Stocks To Own Right Now: (LGEAF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Coherent’s ELA deposition technology for LTPS backplane isn’t used in OLED TVs, where LG (OTC:LGEAF) uses metal oxide backpanes. There was some worry by analysts whether that technology could migrate to the smartphone panel market which CEO Ambroseo could not dispel entirely, but he argued that it has not been demonstrated suitable for handsets or battery-powered devices at this point.

Top 10 High Tech Stocks To Own Right Now: Nexstar Broadcasting Group Inc.(NXST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ:NXST) had its price target cut by B. Riley to $87.00. They currently have a buy rating on the stock.

    Ralph Lauren (NYSE:RL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Ralph Lauren outperformed the industry in the past six months backed by robust bottom-line performance in recent quarters. Notably, third-quarter fiscal 2018 marked the company’s 12th consecutive earnings beat while sales lagged estimates after a beat in the previous quarter. Additionally, the company’s Way Forward Plan is on track, and it remains keen on bolstering digital and international presence. Also, the company has been gaining from favorable geographic and channel mix shifts along with lower promotions and reduced product costs. Further, management adjusted fiscal 2018 outlook to account for the positive currency rates, which are likely to aid revenues and operating margins. However, its North America business continues to suffer due to distribution and brand exits, planned reduction in shipments and promotions to enhance the quality of sales, and lower customer demand.”

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ: NXST) and Liberty Media Formula One Series C (NASDAQ:FWONK) are both mid-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Nexstar Media Group (NXST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now

LISTEN TO ARTICLE 2:14 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

If cryptocurrency markets want to move from the fringes of finance into the mainstream, they’ll need to make some changes.

That’s according to a new report on best practices for digital-asset exchanges, which have been dogged by everything from market manipulation to cyberthefts and questionable data. Authored by the Asia Securities Industry & Financial Markets Association, whose members include Goldman Sachs Group Inc. and BlackRock Inc., the report is the first of its kind by a major financial sector trade group.

Best Heal Care Stocks To Invest In Right Now: Cullen/Frost Bankers, Inc.(CFR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Cullen/Frost Bankers (CFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Anders Bylund, Jason Hall, Danny Vena, Jordan Wathen, and Brian Feroldi]

    In that spirit, we asked a few of our Motley Fool investors what they see as the best investment ideas at the start of July, 2018. They were quick to suggest Chinese e-commerce giantBaidu(NASDAQ:BIDU), coffee giant Starbucks (NASDAQ:SBUX), clean energy specialist TerraForm Power (NASDAQ:TERP), semiconductor veteran Intel, (NASDAQ:INTC), and Texan bankCullen/Frost Bankers(NYSE:CFR).

  • [By Ethan Ryder]

    News articles about Cullen/Frost Bankers (NYSE:CFR) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Cullen/Frost Bankers earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news stories about the bank an impact score of 46.1866283388257 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Joseph Griffin]

    BlackRock Inc. grew its stake in shares of Cullen/Frost Bankers, Inc. (NYSE:CFR) by 2.8% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,251,719 shares of the bank’s stock after acquiring an additional 140,956 shares during the period. BlackRock Inc. owned about 8.23% of Cullen/Frost Bankers worth $557,051,000 at the end of the most recent quarter.

Best Heal Care Stocks To Invest In Right Now: United Fire Group, Inc(UFCS)

Advisors’ Opinion:

  • [By Stephan Byrd]

    United Fire Group (NASDAQ:UFCS) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Lee Jackson]

    United Fire Group Inc. (NASDAQ: UFCS) was downgraded to hold from buy at Sandler ONeill. The 52-week trading range for the shares has been $38.95 to $58.46. The stock closed Monday at $56, so this could be another valuation call.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on United Fire Group (UFCS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: KLX Inc.(KLXI)

Advisors’ Opinion:

  • [By Logan Wallace]

    OppenheimerFunds Inc. decreased its position in KLX Inc (NASDAQ:KLXI) by 16.2% in the 1st quarter, Holdings Channel reports. The firm owned 7,067 shares of the aerospace company’s stock after selling 1,367 shares during the period. OppenheimerFunds Inc.’s holdings in KLX were worth $502,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Max Byerly]

    BidaskClub downgraded shares of KLX (NASDAQ:KLXI) from a buy rating to a hold rating in a report released on Tuesday morning.

    KLXI has been the subject of several other reports. SunTrust Banks cut shares of KLX from a buy rating to a hold rating and set a $53.00 target price for the company. in a report on Wednesday, May 2nd. Zacks Investment Research cut shares of KLX from a buy rating to a hold rating in a report on Saturday, February 17th. TheStreet cut shares of KLX from a b rating to a c+ rating in a report on Tuesday, March 6th. Finally, Jefferies Group upgraded shares of KLX from a hold rating to a buy rating in a report on Wednesday, March 7th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company presently has an average rating of Hold and a consensus target price of $66.50.

  • [By Lou Whiteman]

    Wesco Aircraft (NYSE:WAIR) has found it difficult to compete against archrival KLX (NASDAQ:KLXI) in recent years, suspending guidance last year and thenreporting an unexpected full-fiscal-year loss. Wesco has been mounting a comeback lately, but the company’s challenges are set to intensify after Boeing (NYSE:BA) announced plans to buy KLX for $4.25 billion.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on KLX (KLXI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Invest In Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Max Byerly]

    News headlines about Intercept Pharmaceuticals (NASDAQ:ICPT) have trended somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Intercept Pharmaceuticals earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.6381898611919 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we picked the brains of three Motley Fool investors to gauge what biotech stock they believe investors should consider buying right now. Topping the list were mid-caps Intercept Pharmaceuticals (NASDAQ:ICPT) and Xencor (NASDAQ:XNCR), as well as biotech blue-chip Celgene (NASDAQ:CELG).

Best Heal Care Stocks To Invest In Right Now: United States Steel Corporation(X)

Advisors’ Opinion:

  • [By ]

    Names like U.S. Steel (NYSE: X), Nucor Corp (NYSE: NUE), and AK Steel Holdings (NYSE: AKS) all had an initial bump higher upon the announcement of the tariffs. But the excitement soon faded, with prices plunging back lower. The market is making it clear that tariffs of any kind are not welcome!

  • [By Joseph Griffin]

    Commerzbank Aktiengesellschaft FI trimmed its holdings in shares of U.S. Steel (NYSE:X) by 3.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 121,345 shares of the basic materials company’s stock after selling 4,606 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in U.S. Steel were worth $4,270,000 as of its most recent SEC filing.

  • [By ]

    You can see why Century Aluminum (Nasdaq: CENX) commended the President for “acting swiftly and boldly to save the American aluminum industry.” The company intends to ramp up operations at its smelter in Hawesville, Kentucky, putting 300 people back to work. In Illinois, US Steel (NYSE: X) is restarting a blast furnace that will employ at least 500 new workers.

  • [By Matthew DiLallo]

    Shares of U.S. Steel (NYSE:X) have been red-hot over the past year, surging nearly 60%. Driving those gains has been a significant improvement in the company’s earnings due to higher steel prices. In the first quarter, the steelmaker reported $57 million, or $0.32 per share, of adjusted earnings, which was a vast improvement from the adjusted loss of $145 million, or $0.83 per share, it reported in the year-ago quarter.

Top 5 Undervalued Stocks To Buy For 2018

Shares of Gilead Sciences (GILD) have risen by over 10% since my initial article in April which called the stock a core buy in biotech with several value drivers.

GILD data by YCharts

Long time readers know that I麓m a fan of value catalyst plays, as being undervalued by itself is not a reason for me to be interested in a stock. Too often, selections we deem 篓cheap篓 or a 篓buy the dip篓 play can continue to stay cheap or head south unless there is a catalyst present to turn the ship around.

In my July update piece titled 篓Vosevi EU Approval Just One Of Several Catalysts On The Way篓 we looked at several material events that could cause shares to surge higher. While they initially did just that, unfortunately a pullback in the biotech sector brought the stock back to levels it was previously at.

Top 5 Undervalued Stocks To Buy For 2018: First Trust NASDAQ-100- Technology Index Fund(QTEC)

Advisors’ Opinion:

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Amazon.com, Inc. (NASDAQ: AMZN): Free Stock Analysis Report
     
    Netflix, Inc. (NASDAQ: NFLX): Free Stock Analysis Report
     
    Facebook, Inc. (NASDAQ: FB): Free Stock Analysis Report
     
    Alphabet Inc. (NASDAQ: GOOGL): Free Stock Analysis Report
     
    Apple Inc. (NASDAQ: AAPL): Free Stock Analysis Report
     
    SPDR-TECH SELS (ETF:XLK): ETF Research Reports
     
    NASDAQ-100 SHRS (NASDAQ: QQQ): ETF Research Reports
     
    SPDR-SP 500 TR (ETF:SPY): ETF Research Reports
     
    PWRSH-DYN SEMI (ETF:PSI): ETF Research Reports
     
    ISHARS-NA TEC-S (ETF:IGV): ETF Research Reports
     
    FIRST N-100 TEC (NASDAQ: QTEC): ETF Research Reports
     
    FT-TECH ALPHA (ETF:FXL): ETF Research Reports
     
    FT-NDQ SEMICON (FTXL): ETF Research Reports
     
    NVIDIA Corporation (NASDAQ: NVDA): Free Stock Analysis Report
     
    Macy's Inc (NYSE: M): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research
     
    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Top 5 Undervalued Stocks To Buy For 2018: Nutraceutical International Corporation(NUTR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Monday. Top gainers in the sector included Nutraceutical Int'l Corp. (NASDAQ: NUTR), BRF SA (ADR) (NYSE: BRFS), and Chefs' Warehouse Inc (NASDAQ: CHEF).

Top 5 Undervalued Stocks To Buy For 2018: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Paul Ausick]

    Intercept Pharmaceuticals Inc. (NASDAQ: ICPT) dropped more than 17% Friday to post a new 52-week low of $60.97 after closing Thursday at $73.70. The 52-week high is $172.75. Volume of more than 10 million shares traded was about 12 times the daily average. The FDA on Thursday issued a warning letter on the company’s liver disease treatment.

  • [By Peter Graham]

    Small cap liver biopharmaceutical stock Intercept Pharmaceuticals Inc (NASDAQ: ICPT) reportedQ2 2017 earnings before the market opened on Monday with both the top and bottom lines beating expectations plus the Companyreported that amid-stage clinical trial met its primary endpoint; but sharesended the day down13.26%. Intercept Pharmaceuticals recognized $30.4 million of net sales of Ocaliva for Q2 2017 versus $75k and a net loss of $86.6 million versus a net loss of $77.3 million. Ocaliva was approved by the U.S.FDA in May 2016 for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. As of June 30, 2017,the Companyhad cash, cash equivalents and investment securities available for sale of approximately $550.3 million versus$689.4 million as of December 31, 2016. The CEO commented:

Top 5 Undervalued Stocks To Buy For 2018: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of David Swensen’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=David+Swensen

    These are the top 5 holdings of David SwensenJBG SMITH Properties (JBGS) – 5,145,068 shares, 40.61% of the total portfolio. New PositionAntero Midstream GP LP (AMGP) – 5,769,780 shares, 27.25% of the total portfolio. Shares added by 3.89%Antero Resources Corp (AR) – 3,674,487 shares, 16.87% of the total portfolio. Shares reduced by 6.35%iShares MSCI EAFE (EFA) – 967,022 shares, 15.28% of the total portfolio. Shares reduced by 61.75%iShares China Large-Cap (FXI) – 0 shares, 0% of the

  • [By WWW.MONEYSHOW.COM]

    Meanwhile, international stocks look better than U.S. stocks. The iShares MSCI EAFE Index Fund (EFA) is an ETF that offers international exposure to developed countries in Western Europe, Japan and Australia.

  • [By WWW.GURUFOCUS.COM]

    For the details of SWISS RE LTD’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=SWISS+RE+LTD

    These are the top 5 holdings of SWISS RE LTDiShares Core S&P 500 (IVV) – 1,274,000 shares, 41.43% of the total portfolio. Shares added by 114.84%SPDR S&P 500 (SPY) – 1,192,350 shares, 38.52% of the total portfolio. Shares added by 158.64%iShares MSCI EAFE (EFA) – 1,043,001 shares, 8.7% of the total portfolio. Shares added by 12.39%iShares Floating Rate Bond (FLOT) – 1,000,000 shares, 7.33% of the total portfolio. NewStar Financial Inc (NEWS) – 3,000,000 shares, 4.01%

Top 5 Undervalued Stocks To Buy For 2018: Arista Networks, Inc.(ANET)

Advisors’ Opinion:

  • [By Simon Erickson]

    Arista Networks (NYSE:ANET) founder/Chairman Andy Bechtolsheim became a Silicon Valley legend after being one of the first investors in the company now called Alphabet (NASDAQ:GOOGL), cutting the company a $100,000 check in 1998 before it had even formally selected a name (he confirmed this investment has personally netted him more than $1 billion).

    Arista’s customer count has increased sixfold during the past four years (from 570 in 2011 to more than 3,500 today) and their market share in high-speed data center switching has increased from 3% to 12% during the same time frame. Bechtolsheim owns 19% of Arista’s shares, with insiders collectively owning more than 44%. Due to massive amounts of data being transferred across the Internet (thanks to high-definition video, genomic sequencing, and a ton of other formats), investment in cloud-computing infrastructure is estimated to grow from $32.6 billion in 2015 to $53.1 billion by 2019. 

  • [By Lisa Levin]

    Shares of Arista Networks Inc (NYSE: ANET) got a boost, shooting up 17 percent to $117.47 after the company reported better-than-expected results for its fourth quarter and issued a strong outlook for the current quarter.

  • [By Billy Duberstein]

    Furthermore, if the company were thinking along these lines it would be due to competitive pressures. For years, Cisco’s switching software was only available on its own high-margin hardware; however, the data center switching industry is changing, as competitors like Arista Networks (NYSE:ANET) are winning market share by offering low-cost switches with high functionality. In the past year or two, though, an even greater threat to the industry has emerged, as smaller networking companies started selling stand-alone software that could be run on low-end “whitebox” switches made by low-cost Asian vendors.